ADMESCOPE
Admescope is a privately owned preclinical contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with ADME-Tox services. The service offering is widely spread over the whole ADME-Tox area, with a unique expertise in drug metabolism and drug interactions services. The company was established in 2011 and works with high number of customers in 24 countries on 4 continents.
ADMESCOPE
Industry:
Biotechnology Pharmaceutical Veterinary
Founded:
2011-01-01
Address:
Oulu, Oulu, Finland
Country:
Finland
Website Url:
http://www.admescope.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Apache
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-06-06 | MetaSafe AB | MetaSafe AB acquired by Admescope | N/A |
Official Site Inspections
http://www.admescope.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.84 K
- Host name: pp1049.savviihq.com
- IP address: 62.221.208.85
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Admescope"
Who We Are - Admescope
Since 2020, Admescope has been a part of Symeres, with the ability to provide medicinal chemistry and integrated drug discovery & development services through the Symeres …See details»
MercachemSyncom closes the acquisition of Admescope
Nov 9, 2020 MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, today announced that it has acquired Admescope Ltd. based in Oulu, …See details»
Home - Symeres
Nov 22, 2024 Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges. ... ADME-Tox and PK via our Admescope …See details»
MercachemSyncom closes the acquisition of Admescope
MercachemSyncom closes the acquisition of Admescope . Expands portfolio of drug discovery and development services with a premium-quality ADME-Tox platform . Nijmegen (The …See details»
Admescope - LinkedIn
Admescope | 2,710 followers on LinkedIn. ADME-Tox tailored to your needs | Admescope, part of the Symeres organization, is a contract research organisation (CRO) providing the pharmaceutical ...See details»
Admescope - Crunchbase Company Profile & Funding
Admescope is a privately owned preclinical contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with ADME-Tox services. The service …See details»
Admescope - Scientist.com
Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox services. ... Since 2020, …See details»
Specialized and Skilled Team - Admescope
Dr. Outi Kontkanen, the CEO of Admescope organization and a management team member of Symeres, has an extensive global experience in discovery and early preclinical CRO business. Her passion is to harness science for …See details»
Admescope Company Profile 2024: Valuation, Investors …
Admescope General Information Description. Operator of a contract research organization intended to enable accurate knowledge-based decision-making in drug development.See details»
MercachemSyncom Closes the Acquisition of Admescope
Nov 9, 2020 Contacts. Eelco Ebbers, CEO MercachemSyncom +31 24 3723300 Ari Tolonen, CEO Admescope +358 207 429970 Russell Thomas, Head of Business Development +31 615 571 132See details»
Admescope Company Profile - Office Locations, Competitors
Admescope is a contract research organization providing services to pharmaceutical, biotechnology and veterinary industries. It offers in vitro metabolism, in vivo DMPK, drug …See details»
MercachemSyncom : Closes the Acquisition of Admescope
Nov 9, 2020 Expands portfolio of drug discovery and development services with a premium-quality ADME-Tox platform ... -November 09, 2020 at 03:01 am EST - MarketScreenerSee details»
Admescope Company Overview, Contact Details & Competitors
Admescope. Biotechnology Research Northern Finland, Finland 51-200 Employees. Admescope, part of the Symeres organization, is a contract research organisation (CRO) providing the …See details»
Vision, Mission and Core Values – Admescope
Our Vision. To be the leading European provider of high-quality ADME-Tox services. Our Mission. To enable accurate knowledge-based decision-making in drug development via providing top …See details»
Admescope - Overview, News & Similar companies | ZoomInfo.com
Jun 6, 2018 View Admescope (www.admescope.com) location in Northern Ostrobothnia, Finland , revenue, industry and description. Find related and similar companies as well as employees …See details»
Integrated drug discovery and development services – tailored to …
Feb 23, 2023 Admescope has been part of the Symeres organization since late 2020; perhaps you are not aware about our integrated drug discovery (IDD) services with over 600 scientists …See details»
Admescope - YouTube
Admescope is a preclinical contract research organisation (CRO) providing tailor-made ADME-Tox (Absorption, Distribution, Metabolism, Excretion and Toxicity) services for drug discovery …See details»
MercachemSyncom Closes the Acquisition of Admescope
Nov 9, 2020 NIJMEGEN, The Netherlands--(BUSINESS WIRE)-- MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, today announced …See details»
Admescope team welcomes a new CEO!
Sep 1, 2021 We are excited to announce A dmescope team growing with an appointment of Dr Outi Kontkanen as the new CEO from September 1st. Dr Ari Tolonen, former CEO, will …See details»